Munich-headquartered UVC Partners has announced the final close for UVC Partners III on EUR 210m, with its additional founder-backed Opportunity Fund bringing its total deployment capacity to EUR 255m.
Announcement follows a series of discussions with potential strategic and financial investors
Board of the UK-based listed pharmaceuticals company has agreed to the offer
Venture capital firm Felix Capital appoints Susan Lin and Julien Codorniou as its new partners
Private equity suitors could preempt the auction given the popularity of the space